{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:02:53Z","timestamp":1793134973899,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chinese Natural Science Foundation","award":["81100197"],"award-info":[{"award-number":["81100197"]}]},{"name":"Natural Science Foundation of Shanghai","award":["18ZR1438800"],"award-info":[{"award-number":["18ZR1438800"]}]},{"name":"Scientific Research Project of Shanghai Municipal Commission of Health","award":["201540217"],"award-info":[{"award-number":["201540217"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s11010-024-05061-6","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T05:01:50Z","timestamp":1720501310000},"page":"1583-1593","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Niclosamide modulates phenotypic switch and inflammatory responses in human pulmonary arterial smooth muscle cells"],"prefix":"10.1007","volume":"480","author":[{"given":"Yuwen","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugen","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"key":"5061_CR1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMra2000348","volume":"385","author":"PM Hassoun","year":"2021","unstructured":"Hassoun PM (2021) Pulmonary arterial hypertension. N Engl J Med 385:2361\u20132376. https:\/\/doi.org\/10.1056\/NEJMra2000348","journal-title":"N Engl J Med"},{"key":"5061_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","volume":"8","author":"RT Schermuly","year":"2011","unstructured":"Schermuly RT, Ghofrani HA, Wilkins MR, Grimminger F (2011) Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol 8:443\u2013455. https:\/\/doi.org\/10.1038\/nrcardio.2011.87","journal-title":"Nat Rev Cardiol"},{"key":"5061_CR3","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jama.2022.4402","volume":"327","author":"NF Ruopp","year":"2022","unstructured":"Ruopp NF, Cockrill BA (2022) Diagnosis and treatment of pulmonary arterial hypertension: a review. JAMA 327:1379\u20131391. https:\/\/doi.org\/10.1001\/jama.2022.4402","journal-title":"JAMA"},{"key":"5061_CR4","doi-asserted-by":"publisher","first-page":"j5492","DOI":"10.1136\/bmj.j5492","volume":"360","author":"T Thenappan","year":"2018","unstructured":"Thenappan T, Ormiston ML, Ryan JJ, Archer SL (2018) Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ 360:j5492. https:\/\/doi.org\/10.1136\/bmj.j5492","journal-title":"BMJ"},{"key":"5061_CR5","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1093\/cvr\/cvad110","volume":"119","author":"N Zhu","year":"2023","unstructured":"Zhu N, Guo ZF, Kazama K, Yi B, Tongmuang N, Yao H, Yang R, Zhang C, Qin Y, Han L, Sun J (2023) Epigenetic regulation of vascular smooth muscle cell phenotypic switch and neointimal formation by PRMT5. Cardiovasc Res 119:2244\u20132255. https:\/\/doi.org\/10.1093\/cvr\/cvad110","journal-title":"Cardiovasc Res"},{"key":"5061_CR6","doi-asserted-by":"publisher","first-page":"103559","DOI":"10.1016\/j.drudis.2023.103559","volume":"28","author":"B Ma","year":"2023","unstructured":"Ma B, Cao Y, Qin J, Chen Z, Hu G, Li Q (2023) Pulmonary artery smooth muscle cell phenotypic switching: a key event in the early stage of pulmonary artery hypertension. Drug Discov Today 28:103559. https:\/\/doi.org\/10.1016\/j.drudis.2023.103559","journal-title":"Drug Discov Today"},{"key":"5061_CR7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","volume":"16","author":"GL Basatemur","year":"2019","unstructured":"Basatemur GL, Jorgensen HF, Clarke MCH, Bennett MR, Mallat Z (2019) Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol 16:727\u2013744. https:\/\/doi.org\/10.1038\/s41569-019-0227-9","journal-title":"Nat Rev Cardiol"},{"key":"5061_CR8","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1111\/bph.14375","volume":"176","author":"TE Scott","year":"2019","unstructured":"Scott TE, Kemp-Harper BK, Hobbs AJ (2019) Inflammasomes: a novel therapeutic target in pulmonary hypertension? Br J Pharmacol 176:1880\u20131896. https:\/\/doi.org\/10.1111\/bph.14375","journal-title":"Br J Pharmacol"},{"key":"5061_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41569-019-0242-x","volume":"17","author":"L Southgate","year":"2020","unstructured":"Southgate L, Machado RD, Graf S, Morrell NW (2020) Molecular genetic framework underlying pulmonary arterial hypertension. Nat Rev Cardiol 17:85\u201395. https:\/\/doi.org\/10.1038\/s41569-019-0242-x","journal-title":"Nat Rev Cardiol"},{"key":"5061_CR10","doi-asserted-by":"publisher","first-page":"D13","DOI":"10.1016\/j.jacc.2013.10.035","volume":"62","author":"F Soubrier","year":"2013","unstructured":"Soubrier F, Chung WK, Machado R, Grunig E, Aldred M, Geraci M, Loyd JE, Elliott CG, Trembath RC, Newman JH, Humbert M (2013) Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol 62:D13-21. https:\/\/doi.org\/10.1016\/j.jacc.2013.10.035","journal-title":"J Am Coll Cardiol"},{"key":"5061_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.yjmcc.2021.07.010","volume":"161","author":"P Li","year":"2021","unstructured":"Li P, Song J, Du H, Lu Y, Dong S, Zhou S, Guo Z, Wu H, Zhao X, Qin Y, Zhu N (2021) MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-\u03b21\/smad2\/3 signaling. J Mol Cell Cardiol 161:9\u201322. https:\/\/doi.org\/10.1016\/j.yjmcc.2021.07.010","journal-title":"J Mol Cell Cardiol"},{"key":"5061_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0068-3","volume":"50","author":"Z Cai","year":"2018","unstructured":"Cai Z, Li J, Zhuang Q, Zhang X, Yuan A, Shen L, Kang K, Qu B, Tang Y, Pu J, Gou D, Shen J (2018) MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-beta1 and IL-6\/STAT3 signaling pathways. Exp Mol Med 50:1\u201311. https:\/\/doi.org\/10.1038\/s12276-018-0068-3","journal-title":"Exp Mol Med"},{"key":"5061_CR13","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1093\/eurheartj\/ehs060","volume":"35","author":"M Brock","year":"2014","unstructured":"Brock M, Samillan VJ, Trenkmann M, Schwarzwald C, Ulrich S, Gay RE, Gassmann M, Ostergaard L, Gay S, Speich R, Huber LC (2014) AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension. Eur Heart J 35:3203\u20133211. https:\/\/doi.org\/10.1093\/eurheartj\/ehs060","journal-title":"Eur Heart J"},{"key":"5061_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20101812","volume":"208","author":"A Courboulin","year":"2011","unstructured":"Courboulin A, Paulin R, Giguere NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, Cote J, Simard MJ, Bonnet S (2011) Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 208:535\u2013548. https:\/\/doi.org\/10.1084\/jem.20101812","journal-title":"J Exp Med"},{"key":"5061_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.7326\/0003-4819-102-4-550","volume":"102","author":"RD Pearson","year":"1985","unstructured":"Pearson RD, Hewlett EL (1985) Niclosamide therapy for tapeworm infections. Ann Intern Med 102:550\u2013551. https:\/\/doi.org\/10.7326\/0003-4819-102-4-550","journal-title":"Ann Intern Med"},{"key":"5061_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.lfs.2018.12.061","volume":"220","author":"R Boyapally","year":"2019","unstructured":"Boyapally R, Pulivendala G, Bale S, Godugu C (2019) Niclosamide alleviates pulmonary fibrosis in vitro and in vivo by attenuation of epithelial-to-mesenchymal transition, matrix proteins & Wnt\/beta-catenin signaling: a drug repurposing study. Life Sci 220:8\u201320. https:\/\/doi.org\/10.1016\/j.lfs.2018.12.061","journal-title":"Life Sci"},{"key":"5061_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232416116","author":"Z Wang","year":"2022","unstructured":"Wang Z, Ren J, Du J, Wang H, Liu J, Wang G (2022) Niclosamide as a promising therapeutic player in human cancer and other diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232416116","journal-title":"Int J Mol Sci"},{"key":"5061_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canlet.2014.04.003","volume":"349","author":"Y Li","year":"2014","unstructured":"Li Y, Li PK, Roberts MJ, Arend RC, Samant RS, Buchsbaum DJ (2014) Multi-targeted therapy of cancer by niclosamide: a new application for an old drug. Cancer Lett 349:8\u201314. https:\/\/doi.org\/10.1016\/j.canlet.2014.04.003","journal-title":"Cancer Lett"},{"key":"5061_CR19","doi-asserted-by":"publisher","unstructured":"de Almeida L, da Silva ALN, Rodrigues TS, Oliveira S, Ishimoto AY, Seribelli AA, Becerra A, Andrade WA, Ataide MA, Caetano CCS, de Sa KSG, Pelisson N, Martins RB, de Paula Souza J, Arruda E, Batah SS, Castro R, Frantz FG, Cunha FQ, Cunha TM, Fabro AT, Cunha LD, Louzada-Junior P, de Oliveira RDR and Zamboni DS (2022) Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection. Sci Adv 8:eabo5400. https:\/\/doi.org\/10.1126\/sciadv.abo5400","DOI":"10.1126\/sciadv.abo5400"},{"key":"5061_CR20","doi-asserted-by":"publisher","first-page":"174614","DOI":"10.1016\/j.ejphar.2021.174614","volume":"912","author":"Y Fu","year":"2021","unstructured":"Fu Y, Hu N, Cao M, Li WF, Yang XR, Gao JL, Zhao J, Jiang M, Ma MH, Sun ZJ, Dong DL (2021) Anthelmintic niclosamide attenuates pressure-overload induced heart failure in mice. Eur J Pharmacol 912:174614. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174614","journal-title":"Eur J Pharmacol"},{"key":"5061_CR21","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/bph.14182","volume":"175","author":"XL Xiao","year":"2018","unstructured":"Xiao XL, Hu N, Zhang XZ, Jiang M, Chen C, Ma R, Ma ZG, Gao JL, Xuan XC, Sun ZJ, Dong DL (2018) Niclosamide inhibits vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in injured rat carotid arteries. Br J Pharmacol 175:1707\u20131718. https:\/\/doi.org\/10.1111\/bph.14182","journal-title":"Br J Pharmacol"},{"key":"5061_CR22","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00011-015-0888-8","volume":"64","author":"M Huang","year":"2015","unstructured":"Huang M, Qiu Q, Zeng S, Xiao Y, Shi M, Zou Y, Ye Y, Liang L, Yang X, Xu H (2015) Niclosamide inhibits the inflammatory and angiogenic activation of human umbilical vein endothelial cells. Inflamm Res 64:1023\u20131032. https:\/\/doi.org\/10.1007\/s00011-015-0888-8","journal-title":"Inflamm Res"},{"key":"5061_CR23","doi-asserted-by":"publisher","first-page":"173438","DOI":"10.1016\/j.ejphar.2020.173438","volume":"887","author":"CL Braga","year":"2020","unstructured":"Braga CL, Felix NS, Teixeira DE, Vieira JB, Silva-Aguiar RP, Bose RM, Antunes MA, Rocha NN, Caruso-Neves C, Cruz FF, Rocco PRM, Silva PL (2020) Niclosamide attenuates lung vascular remodeling in experimental pulmonary arterial hypertension. Eur J Pharmacol 887:173438. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173438","journal-title":"Eur J Pharmacol"},{"key":"5061_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.atherosclerosis.2010.12.024","volume":"215","author":"N Zhu","year":"2011","unstructured":"Zhu N, Zhang D, Chen S, Liu X, Lin L, Huang X, Guo Z, Liu J, Wang Y, Yuan W, Qin Y (2011) Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis 215:286\u2013293. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.12.024","journal-title":"Atherosclerosis"},{"key":"5061_CR25","doi-asserted-by":"publisher","first-page":"L615","DOI":"10.1152\/ajplung.00425.2018","volume":"317","author":"N Zhu","year":"2019","unstructured":"Zhu N, Zhang GX, Yi B, Guo ZF, Jang S, Yin Y, Yang F, Summer R, Sun J (2019) Nur77 limits endothelial barrier disruption to LPS in the mouse lung. Am J Physiol Lung Cell Mol Physiol 317:L615\u2013L624. https:\/\/doi.org\/10.1152\/ajplung.00425.2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"5061_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cytogfr.2004.03.004","volume":"15","author":"EW Raines","year":"2004","unstructured":"Raines EW (2004) PDGF and cardiovascular disease. Cytokine Growth Factor Rev 15:237\u2013254. https:\/\/doi.org\/10.1016\/j.cytogfr.2004.03.004","journal-title":"Cytokine Growth Factor Rev"},{"key":"5061_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12964-022-00993-2","volume":"20","author":"G Cao","year":"2022","unstructured":"Cao G, Xuan X, Hu J, Zhang R, Jin H, Dong H (2022) How vascular smooth muscle cell phenotype switching contributes to vascular disease. Cell Commun Signal 20:180. https:\/\/doi.org\/10.1186\/s12964-022-00993-2","journal-title":"Cell Commun Signal"},{"key":"5061_CR28","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1113\/jphysiol.2012.232306","volume":"590","author":"R Yamin","year":"2012","unstructured":"Yamin R, Morgan KG (2012) Deciphering actin cytoskeletal function in the contractile vascular smooth muscle cell. J Physiol 590:4145\u20134154. https:\/\/doi.org\/10.1113\/jphysiol.2012.232306","journal-title":"J Physiol"},{"key":"5061_CR29","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1161\/ATVBAHA.107.159327","volume":"28","author":"AC Doran","year":"2008","unstructured":"Doran AC, Meller N, McNamara CA (2008) Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28:812\u2013819. https:\/\/doi.org\/10.1161\/ATVBAHA.107.159327","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5061_CR30","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/nm.3699","volume":"20","author":"H Tao","year":"2014","unstructured":"Tao H, Zhang Y, Zeng X, Shulman GI, Jin S (2014) Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice. Nat Med 20:1263\u20131269. https:\/\/doi.org\/10.1038\/nm.3699","journal-title":"Nat Med"},{"key":"5061_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.phrs.2016.11.008","volume":"115","author":"SL Li","year":"2017","unstructured":"Li SL, Yan J, Zhang YQ, Zhen CL, Liu MY, Jin J, Gao JL, Xiao XL, Shen X, Tai Y, Hu N, Zhang XZ, Sun ZJ, Dong DL (2017) Niclosamide ethanolamine inhibits artery constriction. Pharmacol Res 115:78\u201386. https:\/\/doi.org\/10.1016\/j.phrs.2016.11.008","journal-title":"Pharmacol Res"},{"key":"5061_CR32","doi-asserted-by":"publisher","first-page":"7770","DOI":"10.1038\/ncomms8770","volume":"6","author":"C He","year":"2015","unstructured":"He C, Medley SC, Hu T, Hinsdale ME, Lupu F, Virmani R, Olson LE (2015) PDGFRbeta signalling regulates local inflammation and synergizes with hypercholesterolaemia to promote atherosclerosis. Nat Commun 6:7770. https:\/\/doi.org\/10.1038\/ncomms8770","journal-title":"Nat Commun"},{"key":"5061_CR33","doi-asserted-by":"publisher","first-page":"H442","DOI":"10.1152\/ajpheart.00165.2008","volume":"296","author":"JA Thomas","year":"2009","unstructured":"Thomas JA, Deaton RA, Hastings NE, Shang Y, Moehle CW, Eriksson U, Topouzis S, Wamhoff BR, Blackman BR, Owens GK (2009) PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns. Am J Physiol Heart Circ Physiol 296:H442\u2013H452. https:\/\/doi.org\/10.1152\/ajpheart.00165.2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5061_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1164\/rccm.200707-1037OC","volume":"178","author":"F Perros","year":"2008","unstructured":"Perros F, Montani D, Dorfmuller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, Herve P, Emilie D, Eddahibi S, Simonneau G, Souza R, Humbert M (2008) Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 178:81\u201388. https:\/\/doi.org\/10.1164\/rccm.200707-1037OC","journal-title":"Am J Respir Crit Care Med"},{"key":"5061_CR35","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1172\/JCI24838","volume":"115","author":"RT Schermuly","year":"2005","unstructured":"Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W, Grimminger F (2005) Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115:2811\u20132821. https:\/\/doi.org\/10.1172\/JCI24838","journal-title":"J Clin Invest"},{"key":"5061_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/cvr\/cvr219","volume":"92","author":"SY Kim","year":"2011","unstructured":"Kim SY, Kwon YW, Jung IL, Sung JH, Park SG (2011) Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCalpha-mediated MKP-1 induction. Cardiovasc Res 92:307\u2013316. https:\/\/doi.org\/10.1093\/cvr\/cvr219","journal-title":"Cardiovasc Res"},{"key":"5061_CR37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1161\/ATVBAHA.112.300645","volume":"33","author":"X Long","year":"2013","unstructured":"Long X, Cowan SL, Miano JM (2013) Mitogen-activated protein kinase 14 is a novel negative regulatory switch for the vascular smooth muscle cell contractile gene program. Arterioscler Thromb Vasc Biol 33:378\u2013386. https:\/\/doi.org\/10.1161\/ATVBAHA.112.300645","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5061_CR38","doi-asserted-by":"publisher","first-page":"19641","DOI":"10.1074\/jbc.M114.630111","volume":"290","author":"XH Liao","year":"2015","unstructured":"Liao XH, Wang N, Zhao DW, Zheng DL, Zheng L, Xing WJ, Ma WJ, Bao LY, Dong J, Zhang TC (2015) STAT3 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin. J Biol Chem 290:19641\u201319652. https:\/\/doi.org\/10.1074\/jbc.M114.630111","journal-title":"J Biol Chem"},{"key":"5061_CR39","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","volume":"54","author":"PM Hassoun","year":"2009","unstructured":"Hassoun PM, Mouthon L, Barbera JA, Eddahibi S, Flores SC, Grimminger F, Jones PL, Maitland ML, Michelakis ED, Morrell NW, Newman JH, Rabinovitch M, Schermuly R, Stenmark KR, Voelkel NF, Yuan JX, Humbert M (2009) Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 54:S10\u2013S19. https:\/\/doi.org\/10.1016\/j.jacc.2009.04.006","journal-title":"J Am Coll Cardiol"},{"key":"5061_CR40","doi-asserted-by":"publisher","first-page":"1152881","DOI":"10.3389\/fimmu.2023.1152881","volume":"14","author":"MQ Zhang","year":"2023","unstructured":"Zhang MQ, Wang CC, Pang XB, Shi JZ, Li HR, Xie XM, Wang Z, Zhang HD, Zhou YF, Chen JW, Han ZY, Zhao LL, He YY (2023) Role of macrophages in pulmonary arterial hypertension. Front Immunol 14:1152881. https:\/\/doi.org\/10.3389\/fimmu.2023.1152881","journal-title":"Front Immunol"},{"key":"5061_CR41","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139067","author":"A Ntokou","year":"2021","unstructured":"Ntokou A, Dave JM, Kauffman AC, Sauler M, Ryu C, Hwa J, Herzog EL, Singh I, Saltzman WM, Greif DM (2021) Macrophage-derived PDGF-B induces muscularization in murine and human pulmonary hypertension. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.139067","journal-title":"JCI Insight"},{"key":"5061_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.470","volume":"8","author":"HJ Sun","year":"2017","unstructured":"Sun HJ, Ren XS, Xiong XQ, Chen YZ, Zhao MX, Wang JJ, Zhou YB, Han Y, Chen Q, Li YH, Kang YM, Zhu GQ (2017) NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension. Cell Death Dis 8:e3074. https:\/\/doi.org\/10.1038\/cddis.2017.470","journal-title":"Cell Death Dis"},{"key":"5061_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s42003-018-0244-y","volume":"2","author":"U Thi Tran","year":"2019","unstructured":"Thi Tran U, Kitami T (2019) Niclosamide activates the NLRP3 inflammasome by intracellular acidification and mitochondrial inhibition. Commun Biol 2:2. https:\/\/doi.org\/10.1038\/s42003-018-0244-y","journal-title":"Commun Biol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05061-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-024-05061-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05061-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T13:17:25Z","timestamp":1740057445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-024-05061-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["5061"],"URL":"https:\/\/doi.org\/10.1007\/s11010-024-05061-6","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"15 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}